Voloridge Investment Management’s Avanos Medical AVNS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-27,984	Closed	-$672K	–	1175
2024 Q3	$672K	Sell	27,984 -20,161	-42%	-$461K	﹤0.01%	1061
2024 Q2	$959K	Sell	48,145 -79,221	-62%	-$1.54M	﹤0.01%	1057
2024 Q1	$2.54M	Buy	127,366 +72,311	+131%	+$1.4M	0.01%	807
2023 Q4	$1.23M	Sell	55,055 -55,304	-50%	-$1.14M	﹤0.01%	920
2023 Q3	$2.23M	Buy	110,359 +92,948	+534%	+$2.11M	0.01%	893
2023 Q2	$445K	Buy	+17,411	New	+$459K	﹤0.01%	1247
2023 Q1	–	Sell	-69,140	Closed	-$1.87M	–	1358
2022 Q4	$1.87M	Sell	69,140 -41,306	-37%	-$1.01M	0.01%	981
2022 Q3	$2.41M	Sell	110,446 -18,076	-14%	-$472K	0.01%	932
2022 Q2	$3.51M	Buy	128,522 +239	+0.2%	+$6.87K	0.02%	803
2022 Q1	$4.3M	Buy	128,283 +20,568	+19%	+$662K	0.02%	687
2021 Q4	$3.73M	Sell	107,715 -18,552	-15%	-$600K	0.02%	820
2021 Q3	$3.94M	Buy	126,267 +64,459	+104%	+$2.19M	0.03%	774
2021 Q2	$2.25M	Buy	+61,808	New	+$2.56M	0.02%	953
2020 Q3	–	Sell	-14,062	Closed	-$413K	–	1241
2020 Q2	$413K	Buy	+14,062	New	+$407K	﹤0.01%	1069
2020 Q1	–	Sell	-6,980	Closed	-$235K	–	1087
2019 Q4	$235K	Buy	+6,980	New	+$253K	﹤0.01%	973
2019 Q2	–	Sell	-20,105	Closed	-$858K	–	755
2019 Q1	$858K	Buy	+20,105	New	+$900K	0.03%	525